- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03315702
Effect of Mechanical Ventilation on Plasma Concentration Level of R-spondin Proteins
the Change of R-spondin Proteins Plasma Concentration Level Caused by Mechanical Ventilation and Its Effect on Mechanical Ventilation Induced Lung Injury
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Mechanical ventilation is a critical intervention for patients with acute respiratory failure. However, lung overdistension induced by mechanical ventilation also causes pulmonary endothelial dysfunction. The injurious effect of mechanical stretch on pulmonary endothelium has been implicated in the development of ventilator-induced lung injury, which is characterized by pulmonary inflammation and particularly increased vascular permeability. In addition, the investigators and others have previously shown that mechanical stretch increases cultured lung endothelial monolayer permeability in vitro and promotes lung vascular permeability in mice Thus, elucidating the mechanisms underlying the mechanical stretch-induced lung endothelial barrier dysfunction may provide a novel clinical therapeutic target against ventilator-induced lung injury.
As novel agonists of Wnt/β-catenin signaling pathway, R-spondin proteins constitute a class of ligands, including R-spondin 1/2/3/4, functioning through their receptors leucine-rich repeat-containing G-protein coupled receptor (LGR)4/5/6 to enhance Wnt/β-catenin activity. Since Wnt signaling plays pivotal roles in the regulation of many life processes involved in embryogenesis and adulthood, R-spondin proteins also take part in cell proliferation, differentiation and morphogenesis. For example, in the formation of respiratory system,R-spondin 2 is required for normal laryngeal-tracheal and lung morphogenesis,and the lack of R-spondin 1 expression results in the absence of duct side-branching development and subsequent alveolar formation. In addition, R-spondins show protective effect in tissue injury and diseases. R-spondin 1 and R-spondin 3 have been reported to prevent chemotherapy- or radiotherapy-induced mucous membrane lesion. R-spondin 1 attenuates oral mucositis contributed by radiotherapy in mouse models and R-spondin 3 potentiates intestinal regeneration elicited via gastrointestinal toxic effect of chemoradiotherapy treatment. However, whether R-spondin proteins exert salient influence on acute lung injury especially induced by mechanical ventilation is deficient. Therefore, this study aims to ascertain the implication of R-spondin proteins in the pathology of mechanical ventilation induced lung injury through detecting human plasma concentration change of R-spondin 1/2/3/4 after mechanical ventilation and interference effects in mouse model, which is helpful for prevention and treatment of ventilation induced lung injury.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200082
- Department of Anesthesia, Shanghai Xinhua hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- undergo elective surgery with mechanical ventilation lasting for > 3 hours; classified as physical status I to III according to the American Society of Anesthesiologists Physical Status Classification System; Written informed consent is approved.
Exclusion Criteria:
- chronic lung disease; recent lung infection; recent anaesthetics or mechanical ventilation treatment; hemodilution with massive fluid supply during surgery; children;women during pregnancy or lactation; being involved in other clinical subjects
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
control/mechanical ventilation
venous blood samples collected from patients twice,relatively before mechanical ventilation and 3rd hour after mechanical ventilation
|
mechanical ventilation protocol: tidal volume 6-8 ml/kg, positive end-expiratory pressure 5 cm H2O, oxygen concentration 40%; respiratory rate 10-15/min, inspiratory/expiratory ratio 1:1.5.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Plasma Concentration of R-spondin 1
Time Frame: 3 hours
|
The venous blood samples were collected twice for each patient that the first time was around the onset of the mechanical ventilation and the second was 3rd hour after the onset of the mechanical ventilation, which were named as sample A and sample B relatively.
Then, plasmids were separated by centrifugation and detected for R-spondin1 concentration.
And the outcome was calculated by subtracting the R-spondin1 plasmid concentration of sample A from the R-spondin1 plasmid concentration of sample B, which was the change in plasma concentration of R-spondin1.
|
3 hours
|
|
Change in Plasma Concentration of R-spondin 2
Time Frame: 3 hours
|
The venous blood samples were collected twice for each patient that the first time was around the onset of the mechanical ventilation and the second was 3rd hour after the onset of the mechanical ventilation, which were named as sample A and sample B relatively.
Then, plasmids were separated by centrifugation and detected for R-spondin2 concentration.
And the outcome was calculated by subtracting the R-spondin2 plasmid concentration of sample A from the R-spondin2 plasmid concentration of sample B, which was the change in plasma concentration of R-spondin2.
|
3 hours
|
|
Change in Plasma Concentration of R-spondin3
Time Frame: 3 hours
|
The venous blood samples were collected twice for each patient that the first time was around the onset of the mechanical ventilation and the second was 3rd hour after the onset of the mechanical ventilation, which were named as sample A and sample B relatively.
Then, plasmids were separated by centrifugation and detected for R-spondin3 concentration.
And the outcome was calculated by subtracting the R-spondin3 plasmid concentration of sample A from the R-spondin3 plasmid concentration of sample B, which was the change in plasma concentration of R-spondin3.
|
3 hours
|
|
Change in Plasma Concentration of R-spondin4
Time Frame: 3 hours
|
The venous blood samples were collected twice for each patient that the first time was around the onset of the mechanical ventilation and the second was 3rd hour after the onset of the mechanical ventilation, which were named as sample A and sample B relatively.
Then, plasmids were separated by centrifugation and detected for R-spondin4 concentration.
And the outcome was calculated by subtracting the R-spondin4 plasmid concentration of sample A from the R-spondin4 plasmid concentration of sample B, which was the change in plasma concentration of R-spondin4.
|
3 hours
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XH-17-015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Lung Injury
-
People's Hospital of Guangxi Zhuang Autonomous...CompletedAcute Lung Injury(ALI)China
-
Shanghai University of Traditional Chinese MedicineRecruitingAcute Respiratory Distress Syndrome (ARDS) | Acute Lung Injury(ALI) | Sepsis Related Acute Lung Injury/Acute Respiratory Distress SyndromeChina
-
Centre Hospitalier Saint Joseph Saint Luc de LyonRecruitingARDS (Acute Respiratory Distress Syndrome)France
-
Ming ZhongNot yet recruitingARDS (Acute Respiratory Distress Syndrome)China
-
Peking Union Medical College HospitalNot yet recruiting
-
University of CalgaryNot yet recruitingARDS (Acute Respiratory Distress Syndrome)
-
Ain Shams UniversityEnrolling by invitationARDS (Acute Respiratory Distress Syndrome)Egypt
-
Ain Shams UniversityCompleted
-
Yongtao SunNot yet recruitingAcute Lung InjuryChina
-
Centre Integre Universitaire de Sante et Services...Not yet recruitingARDS (Acute Respiratory Distress Syndrome) | Invasive Mechanical Ventilation | Patient-Self Inflicted Lung InjuryCanada
Clinical Trials on mechanical ventilation
-
Ruijin HospitalUnknownAcute Pancreatitis | Complication of Ventilation TherapyChina
-
Peking Union Medical College HospitalThe First Affiliated Hospital with Nanjing Medical University; National Natural... and other collaboratorsUnknownAcute Respiratory Failure | Immunocompromised Patients
-
Riphah International UniversityCompletedBurns (Physical Finding)Pakistan
-
Limin ZhuUnknownRight Ventricular Hypertrophy | Congenital Heart Disease | Postoperative Care | Mechanical Ventilation | Heart-lung InteractionChina
-
Karolinska InstitutetCompleted
-
Seoul National University HospitalCompletedVentilation | Out-Of-Hospital Cardiac Arrest | Advanced Cardiac Life SupportKorea, Republic of
-
Beijing Sanbo Brain HospitalRecruiting
-
University of Roma La SapienzaRecruiting
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalRecruitingCOVID-19 Pneumonia | COVID-19 Acute Respiratory Distress SyndromeTurkey
-
Beijing Chao Yang HospitalCompletedInterstitial Lung Disease | Risk Factors | Morality | Mechanical Ventilation